US researchers develop vaccines for Clostridial dermatitis in turkeys

게시됨 2024년 12월 11일

Tridge 요약

The USPOULTRY Foundation and North Carolina State University have completed a study funded by Prestage Farms on using nontoxic segments of C. septicum alpha toxin as a vaccine against Clostridial dermatitis in turkeys. The research identified two probiotic Lactococcus lactis-based vaccines expressing ntATX antigens, which protected turkeys against the disease when administered via parenteral and oral routes. Clostridial dermatitis, caused by Clostridium septicum, is a significant economic problem for the poultry industry.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

USPOULTRY and the USPOULTRY Foundation are announcing the completion of a funded research project by researchers at North Carolina State University, which not only showed that nontoxic segments of C. septicum alpha toxin possess a protective ability against experimental Clostridial dermatitis infection of turkeys and can be suitable vaccine candidates, but also both parenteral and oral routes of vaccination can protect turkeys against Clostridial dermatitis. The research was made possible in part by an endowing USPOULTRY Foundation gift from Prestage Farms. The research is part of USPOULTRY's comprehensive research program encompassing all phases of poultry and egg production and processing. A summary of the completed project: Project #BRF-014, Development of a Probiotic-Based Recombinant Oral Vectored-Vaccine Against Clostridial Dermatitis in Turkeys - Dr. Ravi Kulkarni, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State ...
출처: Provisioner

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.